PIAS4 and cancer: Enhancement of AMPK activity towards mTORC1 and associated cytostatic effects in MDA-MB-231 breast cancer cells following PIAS4 depletion indicate that inhibition of AMPKα1 SUMOylation could provide a specific way to inhibit cancers with hyperactive mTORC1 signalling.